News Focus
News Focus
icon url

drbio45

08/28/17 8:27 AM

#213286 RE: n4807g #213285

Kite was probably going to charge 500 thousand a year for their drug

will Gilead be able to do that?
icon url

lgonber

08/28/17 8:28 AM

#213287 RE: n4807g #213285

I would bet on JUNO, as CELG bought shares at double price of what they are now, just approx two years ago and they have a patent dispute with KITE